HSIC earnings: real EPS beat/miss history, analyst consensus Buy, P/E 25.39. Updated 2026-07-23.
Henry Schein (HSIC) Research Hub
Henry Schein (HSIC) trades on NASDAQ, US in the Healthcare (Medical - Distribution) sector. As of 2026-09-11, shares last closed at 88.36 USD (+0.44%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 25.39, market cap 9.65B. This hub links to the full technical, earnings and options research available for HSIC.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Distribution) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 88.36 USD (+0.44%) |
| 52-week range | 78.62 USD – 92.18 USD |
| Trend regime | Range |
| 14-day RSI | 50.9 (Neutral) |
| Trailing P/E | 25.39 |
| Market cap | 9.65B |
| Dividend yield | 0.00% |
Available research for HSIC
Covered Call on HSIC: how it works, illustrative setup around the real 88.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HSIC: how it works, illustrative setup around the real 88.36 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HSIC: how it works, illustrative setup around the real 88.36 USD price, max profit/loss, breakeven and when to use it. Educational.
HSIC technical analysis: range, last 88.36 USD, RSI 50.9, 52w range 78.62 USD–92.18 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HSIC in?
Henry Schein (HSIC) is classified under Healthcare (Medical - Distribution), listed on NASDAQ, US.
Is HSIC in an uptrend or downtrend?
As of 2026-09-11, HSIC is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HSIC's trailing P/E ratio?
HSIC's trailing P/E is 25.39, with a market cap of 9.65B. See the earnings research page for full valuation detail.